<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Headache and Pain</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1129-2369</issn>
      <issn pub-type="epub">1129-2377</issn>
      <publisher>
        <publisher-name>Springer Milan</publisher-name>
        <publisher-loc>Milan</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34503441</article-id>
      <article-id pub-id-type="pmc">8428097</article-id>
      <article-id pub-id-type="publisher-id">1318</article-id>
      <article-id pub-id-type="doi">10.1186/s10194-021-01318-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-state fMRI study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Dai</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Qiu</surname>
            <given-names>Enchao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yun</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xing</surname>
            <given-names>Xinbo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xi</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Meichen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Ke</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>Lixia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Dong</surname>
            <given-names>Zhao</given-names>
          </name>
          <address>
            <email>dong_zhaozhao@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yu</surname>
            <given-names>Shengyuan</given-names>
          </name>
          <address>
            <email>yushengyuan@301hospital.com.cn</email>
            <email>yusy1963@126.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.414252.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1761 8894</institution-id><institution>Department of Neurology, </institution><institution>Chinese PLA General Hospital, </institution></institution-wrap>28 Fuxing Road, 100853 Beijing, China </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.488137.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2267 2324</institution-id><institution>Chinese PLA Medical School, </institution></institution-wrap>100853 Beijing, China </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.414252.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1761 8894</institution-id><institution>Department of Radiology, </institution><institution>Fourth Medical Center of Chinese PLA General Hospital, </institution></institution-wrap>100048 Beijing, China </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.181531.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1789 9622</institution-id><institution>School of Computer and Information Technology, </institution><institution>Beijing Jiaotong University, </institution></institution-wrap>100044 Beijing, China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>9</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>22</volume>
      <issue>1</issue>
      <elocation-id>107</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>6</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>8</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p id="Par1">Medication-overuse headache (MOH) is a relatively frequently occurring secondary headache caused by overuse of analgesics and/or acute migraine medications. It is believed that MOH is associated with dependence behaviors and substance addiction, in which the salience network (SN) and the habenula may play an important role. This study aims to investigate the resting-state (RS) functional connectivity between the habenula and the SN in patients with MOH complicating chronic migraine (CM) compared with those with episodic migraine (EM) and healthy controls (HC).</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p id="Par2">RS-fMRI and 3-dimensional T1-weighted images of 17 patients with MOH + CM, 18 patients with EM and 30 matched healthy HC were obtained. The RS-fMRI data were analyzed using the independent component analysis (ICA) method to investigate the group differences of functional connectivity between the habenula and the SN in three groups. Correlation analysis was performed thereafter with all clinical variables by Pearson correlation.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p id="Par3">Increased functional connectivity between bilateral habenula and SN was detected in patients with MOH + CM compared with patients with EM and HC respectively. Correlation analysis showed significant correlation between medication overuse duration and habenula-SN connectivity in MOH + CM patients.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p id="Par4">The current study supported MOH to be lying within a spectrum of dependence and addiction disorder. The enhanced functional connectivity of the habenula with SN may correlate to the development or chronification of MOH. Furthermore, the habenula may be an indicator or treatment target for MOH for its integrative role involved in multiple aspects of MOH.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Medication-overuse headache</kwd>
        <kwd>Migraine</kwd>
        <kwd>Salience network</kwd>
        <kwd>Habenula</kwd>
        <kwd>Resting-state fMRI</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
              <institution>National Natural Science Foundation of China</institution>
            </institution-wrap>
          </funding-source>
          <award-id>82071226</award-id>
          <award-id>81671077</award-id>
          <award-id>Z170002</award-id>
          <principal-award-recipient>
            <name>
              <surname>Yu</surname>
              <given-names>Shengyuan</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>© The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p id="Par24">Medication-overuse headache (MOH) is a secondary chronic disorder attributed to overuse of acute or symptomatic headache medications that develops in patients with a pre-existing primary headache, especially migraine [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The 1-year relapse rate of MOH patients could reach to 24.8 %, and two-thirds of MOH patients fulfill the criteria for substance addiction [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. Neuroimaging, genetic and biological studies indicated that MOH shares similar imaging features, associated gene polymorphisms, and neurobiological changes with substance addiction [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. In addition, MOH patients can develop behaviors including ritualized drugs intake, psychological drug attachment and withdraw symptoms which are believed to be associated with addiction [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p id="Par25">Previous resting-state functional magnetic resonance imaging (RS-fMRI) method has indicated dysregulation of the reward circuit in MOH patients in line with substance abusers [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. And alterations of the functional connectivity between the nucleus accumbens and the salience network (SN) as well as other brain regions in the reward-related circuits have been reported [<xref ref-type="bibr" rid="CR16">16</xref>]. Besides the reward system, addiction is also associated with the enhanced activation of the anti-reward circuit, in which the habenula plays a key role [<xref ref-type="bibr" rid="CR17">17</xref>]. The habenula functions in addiction, cognition, reward, pain and analgesia while the SN is to modulate information via integrating sensory, affective and cognitive inputs, and assigning relevance of the stimuli for continuous processing [<xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. However, few studies to date have focused on habenula and its interaction with the SN.</p>
      <p id="Par26">Therefore, this study aims to investigate the resting-state function connectivity of the habenula and the SN in patients with MOH complicating chronic migraine (CM) compared with those with episodic migraine (EM) and healthy controls (HC). And we also searched for possible correlations between these functional connectivity alterations and clinical features (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Summary of the current study. This figure is a concise summary of the current study. MOH + CM (medication-overuse headache + chronic migraine) was shown as MOH<sup>CM</sup> here for a better layout in this figure. The picture of brain on the right shows the habenula and its connections with other brain regions. The full lines with arrows connect regions which the habenula has afferent inputs from or efferent outputs to on structural basis. The dotted lines represent functional connectivity identified by fMRI studies. Hb, habenula; SNc, substantia nigra pars; IPN, interpeduncular nucleus; DRN, dorsal raphe nucleus; MRN, median raphe nucleus; VTA, ventral tegmental area; PAG, periaqueductal gray; RMTg, rostromedial tegmental nucleus; EP, entopeduncular nucleus; NAc, nucleus accumbens; CP, caudate/putamen; LH, lateral hypothalamic; dACC, dorsal anterior cingulate cortex; mPFC, medial prefrontal cortex</p></caption><graphic xlink:href="10194_2021_1318_Fig1_HTML" id="d32e537"/></fig></p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Participants</title>
        <p id="Par28">All research procedures were approved by the Chinese Ministry of Health and the Ethics Committee of the Chinese PLA General Hospital, Beijing, China, which were conducted in accordance with the ethical principles of the Declaration of Helsinki. Participants were recruited in Chinese PLA General Hospital and received complete description of the study and gave written informed consent before the study.</p>
        <p id="Par29">Patients were recruited consecutively in the International Headache Center in the Chinese PLA General Hospital from May 2018 to April 2019. All HC had no primary headaches or other chronic pain disorders. The included criteria of MOH and EM were as follows: (1) The diagnosis of MOH and EM met the criteria of the International Classification of Headache Disorders 3rd edition (ICHD-3) [<xref ref-type="bibr" rid="CR22">22</xref>]; (2) All MOH patients were confirmed to be with a prior migraine based on their past history. Thus, according to ICHD-3, these patients should be given the diagnosis of MOH + chronic migraine (CM); (3) EM patients were excluded if they had suffered a prior episode of MOH; (4) Without migraine preventive medication in the past 3 months. The excluded criteria were as follows: (1) With chronic disorders including hypertension, diabetes mellitus, cardiovascular diseases, ischemia etc.; (2) With cranium trauma, psychotic disorder, or regular use of a psychoactive or hormone medication. All participants were right hand dominant and reported no other neurologic or psychiatric disorder. The evaluations of participants were conducted by 2 neurologists. Meanwhile clinical data as well as the Patient Health Questionnaire 9 Depression Scale (PHQ-9) and Generalized Anxiety Disorder Assessment 7-item Scale (GAD-7) were collected before MRI scan. MRI scans were taken at least 24 h after the latest migraine attack for MOH or EM patients. The alcohol, nicotine, caffeine and other substances were avoided at least 24 h before MRI examination.</p>
      </sec>
      <sec id="Sec4">
        <title>MRI data acquisition</title>
        <p id="Par30">All MRI studies were performed on a 3.0T Siemens scanner. The RS-fMRI were acquired right after localizer images. Then whole-brain 3-dimensional T1-weighted images of each one was then obtained as sagittal view (repetition time = 2500 ms, echo time = 3.5 ms, flip angle = 8°, field of view = 256 × 256 mm<sup>2</sup>, Matrix = 256 × 256, slices = 192, thickness = 1 mm, interslice gap = 0.6 mm). RS-fMRI were obtained using a gradient echo-planar imaging (EPI) sequence (repetition time = 2000 ms, echo time = 30 ms, flip angle = 90<sup>◦</sup>, slice thickness = 3 mm, slice gap = 0.6 mm, field of view = 200 × 200 mm<sup>2</sup>, Matrix = 64 × 64). For all of the participants, the structural images were examined to exclude the possibility of lesions by 2 radiologists.</p>
      </sec>
      <sec id="Sec5">
        <title>RS-fMRI data preprocessing</title>
        <p id="Par31">The RS-fMRI data were preprocessing using the FMRIB’s Software Library (FSL) tools (<ext-link ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl/)">http://www.fmrib.ox.ac.uk/fsl/)</ext-link>[<xref ref-type="bibr" rid="CR23">23</xref>].The RS-fMRI data were processed by the following steps as performed in previous studies [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>]. They were: (1) removing the first 5 volumes, (2) correcting the head motion by MCFLIRT, (3) removing the nonbrain tissues by BET (Brain Extraction Tool), (4) spatial smoothing using a 4-mm FWHM (full width at half maximum) Gaussian kernel, (5) removing slow drift with a high-pass temporal filter of 0.01 Hz, and (6) registering the RS-fMRI data to the 3-dimensional T1-weighted images and then to Montreal Neurological Institute-152 standard space. The registered RS-fMRI data were finally resampled to 2 × 2 × 2 mm.</p>
      </sec>
      <sec id="Sec6">
        <title>TC-GICA and dual-regression</title>
        <p id="Par32">The temporal-concatenation group independent component analysis (TC-GICA) on the datasets of 30 healthy volunteers were created using the MELODIC (Multivariate Exploratory Linear Optimized Decomposition into Independent Components) tool in FSL [<xref ref-type="bibr" rid="CR27">27</xref>]. The number of components was fixed at 50. Then we built individual-subject-level spatial maps by applying dual regression to the preprocessed RS-fMRI data of each participant by using the same approach. For each subject, firstly we used the previously obtained GICA spatial maps to regress against the individual’s preprocessed RS-fMRI data to estimate the matrices of network time series of each component. Secondly, the 50 network time series which we obtained were regressed against each subject’s preprocessed 4-dimensional RS-fMRI data to estimate the subject’s network spatial component maps. The independents were demeaned and normalized in both of the 2 steps before being entered into the regression model [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Then we used FSL utility to spatially correlate all the components to Yeo’s 7 network parcellation of cortex with the results of r-value [<xref ref-type="bibr" rid="CR29">29</xref>]. Each component of a resting-state network was ensured that the bulk of its signal falls on the lower end of the power frequency spectrum. Visual inspections were performed as a final check.</p>
      </sec>
      <sec id="Sec7">
        <title>Habenula and SN interaction difference analyses</title>
        <p id="Par33">In our study, we tested the alterations of habenula and SN interaction in patients with MOH + CM and EM. Based on the spatial maps generated by TC-GICA, we identified SN as follows, mainly encompasses the dorsal anterior cingulate cortex (dACC) and bilateral anterior insula/frontal operculum [<xref ref-type="bibr" rid="CR21">21</xref>].Then we got the SN spatial maps which corresponded to each brain network across individuals in a 4-dimensional file. And we compared three group of MOH + CM vs. EM vs. HC using ANOVA in DPABI toolkit under MATLABR2013b (version 8.2.0.701) environment, and subsequent LSD test to compare the difference between each two groups [<xref ref-type="bibr" rid="CR30">30</xref>]. PHQ-9 and GAD-7 scale were added as covariates when ANOVA were performed to exclude the effects of depression or anxiety. Finally, we performed FDR (false discovery rate) procedure to correct for multiple comparisons within habenula mask. The habenula masks were manually created for every patient, by using the T1 images to visually identify the right and left habenula of each subject landmark using SPM8 (<ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk/spm/">www.fil.ion.ucl.ac.uk/spm/</ext-link>). In T1 images the habenula is visible as two small epithalamic structures at the dorsomedial portion of thalamus pointing into the third ventricle [<xref ref-type="bibr" rid="CR31">31</xref>]. All the habenula masks were carefully inspected, and the mean MNI coordinates of all the participant-specific habenula masks were approximately centered at [− 4, − 24, 2] for the left habenula and [4, − 24, 2] for the right habenula which were consistent with previous research [<xref ref-type="bibr" rid="CR31">31</xref>]. The habenula masks were defined as a 4-mm sphere centered at [− 4, − 24, 2] and [4, − 24, 2]. As for MOH + CM and EM, each group will be divided into two subgroups based on PHQ-9 scale (subgroup 1 with scores 0–4 and subgroup 2 with scores 5–27), or GAD-7 scale (subgroup 1 with scores 0–4 and subgroup 2 with scores 5–27) to detect if there is a significant difference between the subgroups in MOH + CM or EM. Comparisons of functional connectivity will be performed between two subgroups in order to validate if depression or anxiety affects the functional connectivity.</p>
      </sec>
      <sec id="Sec8">
        <title>Statistical analysis</title>
        <p id="Par34">Analyses of variance with subsequent post-hoc tests, Chi-square tests, or Fisher’s exact tests were used as appropriate for comparing demographic data among participant cohorts. Pearson correlation analysis was performed between functional connectivity of habenula-SN in the imaging and the clinical variables within the patients’ group using SPSS. The data with normal distribution was described as mean ± standard deviation. <italic>P</italic> value of &lt; 0.05 was considered to indicate a statistically significant correlation.</p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="results">
      <title>Results</title>
      <sec id="Sec10">
        <title>Participant characteristics</title>
        <p id="Par35">Table <xref rid="Tab1" ref-type="table">1</xref> shows the demographic and clinical characteristics of the subjects included in this study. Sixty-five subjects were included in the RS-fMRI analysis. Seventeen patients with MOH + CM (3 males and 14 females, mean age 46.6 ± 10.3 years), 18 patients with EM (4 males and 14 females, mean age 38.0 ± 14.4 years) and 30 HC (11 males and 19 females, mean age 40.8 ± 9.7 years). Age and sex did not differ across groups. Disease duration of MOH + CM group (22.8 ± 8.9, range: 3–40 years) was significantly higher (<italic>p</italic> &lt; 0.001) than EM group (10.8 ± 6.9, range: 0.83–20 years). The medication-overuse duration of MOH + CM subjects was 7.3 ± 6.4 with range of 0.25–17 years. The visual analog scale of MOH + CM and EM group resulted no significant difference. The PHQ-9 depression scale of MOH + CM patients (8.7 ± 6.7, range: 0–23) was significantly higher than EM (2.4 ± 4.8 range: 0–11) and HC (2.5 ± 2.2, range: 0–6), with <italic>p</italic> value of 0.018 and 0.002 separately. There was no difference of GAD-7 anxiety scale of participants in three groups. Overused medications were combination analgesics for all MOH + CM participants (chiefly aminopyrine-phenacetin-phenobarbital-caffeine and caffeine-aminopyrine).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical data for all participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Clinical details</th><th align="left">MOH + CM<sup>a</sup> patients</th><th align="left">EM<sup>b</sup> patients</th><th align="left">Healthy controls</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Age, years</td><td align="left">46.6 ± 10.3</td><td align="left">38.0 ± 14.4</td><td align="left">40.8 ± 9.7</td><td align="left">0.078</td></tr><tr><td align="left">Sex</td><td align="left">3M<sup>c</sup>, 14F<sup>d</sup></td><td align="left">4 M, 14 F</td><td align="left">11 M, 19 F</td><td align="left">0.298</td></tr><tr><td align="left">Headache history, years</td><td align="left">22.8 ± 8.9</td><td align="left">10.8 ± 6.9</td><td align="left"> N/A<sup>e</sup></td><td align="left">&lt; 0.001</td></tr><tr><td align="left">Medication-overuse duration, years</td><td align="left">7.3 ± 6.4</td><td align="left"> N/A</td><td align="left">N/A</td><td align="left">N/A</td></tr><tr><td align="left" colspan="5">Headache location</td></tr><tr><td align="left">Right; Left; Bilateral</td><td align="left">2 (11.8 %); 2 (11.8 %); 13 (76.5 %)</td><td align="left">2 (11.1 %); 7 (38.9 %); 9 (50 %)</td><td align="left">N/A; N/A; N/A</td><td align="left">N/A; N/A; N/A</td></tr><tr><td align="left">VAS<sup>f</sup></td><td align="left">8.4 ± 1.4</td><td align="left">8.0 ± 1.4</td><td align="left"> N/A</td><td align="left">0.465</td></tr><tr><td align="left">PHQ9</td><td align="left">8.7 ± 6.7</td><td align="left">2.4 ± 4.8</td><td align="left">2.5 ± 2.2</td><td align="left">&lt; 0.05<sup>h</sup></td></tr><tr><td align="left">GAD-7<sup>i</sup></td><td align="left">2.9 ± 3.9</td><td align="left">1.6 ± 3.6</td><td align="left">2.6 ± 2.1</td><td align="left">0.729</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> MOH + CM, medication-overuse headache + chronic migraine; <sup>b</sup> EM, episodic migraine; <sup>c</sup> M, male; <sup>d</sup> F, female; <sup>e</sup> NA, not applicable; <sup>f</sup> VAS, visual analog scale; <sup>g</sup> PHQ-9, Patient Health Questionnaire 9 Depression Scale; <sup>h</sup> Post-hoc analysis using LSD resulted significant difference between MOH + CM and EM with <italic>p</italic> value of 0.018, MOH + CM with HC with <italic>p</italic> value of 0.002. Meanwhile there was no significant difference between EM and HC with <italic>p</italic> value of 0.978; <sup>i</sup> GAD-7, Generalized Anxiety Disorder Assessment 7-item Scale. Data are mean ± standard deviation</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec11">
        <title>GICA spatial maps</title>
        <p id="Par37">RS-fMRI data were separated from the entire HC group into 50 independent components. We obtained 9 nonartifactual components based on correlation analysis results and visual inspection of each component’s spatial map (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Then we selected the SN on the basis of the r-value and spatial similarity to the reported spatial maps previously [<xref ref-type="bibr" rid="CR32">32</xref>].
<fig id="Fig2"><label>Fig. 2</label><caption><p>Group ICA–estimated resting-state networks based on 50-component analysis. Sagittal, axial, and coronal views of the ICA spatial maps estimated by correlation to the known reference network using FSL utility and confirmed by visual inspections, considering 9 nonartifactual components</p></caption><graphic xlink:href="10194_2021_1318_Fig2_HTML" id="d32e890"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Altered resting-state interaction of the habenula and the SN in patients with MOH + CM</title>
        <p id="Par39">We identified an increased functional connectivity of habenula-SN in both the right and left habenula masks of the MOH + CM subjects compared with EM and HC. While there was no difference detected between EM subjects and HC in the same brain regions. Further details are shown in Table <xref rid="Tab2" ref-type="table">2</xref>; Fig. <xref rid="Fig3" ref-type="fig">3</xref>. No difference was detected between subgroups with or without depression based on PHQ-9 scale in MOH + CM (Table <xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Altered resting-state functional connectivity of the habenula and the SN<sup>a</sup> amongst MOH + CM<sup>b</sup>, EM<sup>c</sup> and HC<sup>d</sup>, and between MOH + CM subgroups with or without depression</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Brain region</th><th align="left" rowspan="2">Number of voxels</th><th align="left" rowspan="2">Cluster size, mm<sup>3</sup></th><th align="left" colspan="3">MNI coordinates, mm</th><th align="left" rowspan="2">F score (max)</th><th align="left" rowspan="2"><italic>p</italic> value</th></tr><tr><th align="left">x</th><th align="left">y</th><th align="left">z</th></tr></thead><tbody><tr><td align="left" colspan="8">MOH + CM VS HC</td></tr><tr><td align="left">  R<sup>e</sup> habenula</td><td char="." align="char">7</td><td char="." align="char">56</td><td align="left">4</td><td align="left">-25</td><td char="." align="char">2</td><td align="left">3.38</td><td align="left">&lt; 0.001</td></tr><tr><td align="left">  L<sup>f</sup> habenula</td><td char="." align="char">7</td><td char="." align="char">56</td><td align="left">-3</td><td align="left">-25</td><td char="." align="char">2</td><td align="left">3.09</td><td align="left">0.002</td></tr><tr><td align="left" colspan="8">MOH + CM VS EM</td></tr><tr><td align="left">  R habenula</td><td char="." align="char">7</td><td char="." align="char">56</td><td align="left">4</td><td align="left">-23</td><td char="." align="char">2</td><td align="left">2.73</td><td align="left">0.006</td></tr><tr><td align="left">   L habenula</td><td char="." align="char">7</td><td char="." align="char">56</td><td align="left">-3</td><td align="left">-23</td><td char="." align="char">2</td><td align="left">3.03</td><td align="left">0.002</td></tr><tr><td align="left" colspan="8">EM VS HC</td></tr><tr><td align="left">  R habenula</td><td char="." align="char">0</td><td char="." align="char">0</td><td align="left">3</td><td align="left">-25</td><td char="." align="char">2</td><td align="left">1.76</td><td align="left">0.079</td></tr><tr><td align="left">   L habenula</td><td char="." align="char">0</td><td char="." align="char">0</td><td align="left">4</td><td align="left">-24</td><td char="." align="char">2</td><td align="left">1.51</td><td align="left">0.132</td></tr><tr><td align="left" colspan="8">MOH + CM <sup>depression</sup> VS MOH + CM <sup>without depression</sup></td></tr><tr><td align="left">  R habenula</td><td char="." align="char">0</td><td char="." align="char">0</td><td align="left">5</td><td align="left">-24</td><td char="." align="char">2</td><td align="left">0.85*</td><td align="left">0.475</td></tr><tr><td align="left">  L habenula</td><td char="." align="char">0</td><td char="." align="char">0</td><td align="left">4</td><td align="left">-24</td><td char="." align="char">2</td><td align="left">1.99*</td><td align="left">0.077</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> SN, salience network; <sup>b</sup> MOH + CM, medication-overuse headache + chronic migraine; <sup>c</sup> EM, episodic migraine; <sup>d</sup> HC, healthy controls; <sup>e</sup> R, right; <sup>f</sup> L, left</p><p>*T score from two-sample t test</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Altered habenula-SN functional connectivity maps. Altered resting-state functional connectivity of habenula and the SN region in MOH + CM vs. that in HC and EM patients. (<bold>A</bold>) the increased resting-state functional connectivity of the left habenula and the SN in patients with MOH + CM compared with HC; (<bold>B</bold>) the increased resting-state functional connectivity of the right habenula and the SN in patients with MOH + CM compared with HC; (<bold>C</bold>) the increased resting-state functional connectivity of the left habenula and the SN in patients with MOH + CM compared with EM; and (<bold>D</bold>) the increased resting-state functional connectivity of the right habenula and the SN in patients with MOH + CM compared with EM. SN, salience network; MOH + CM, medication-overuse headache + chronic migraine; HC, healthy controls; EM, episodic migraine</p></caption><graphic xlink:href="10194_2021_1318_Fig3_HTML" id="d32e1238"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>Correlation analysis between habenula-SN functional connectivity and clinical variables</title>
        <p id="Par42">Table <xref rid="Tab3" ref-type="table">3</xref>; Fig. <xref rid="Fig4" ref-type="fig">4</xref> presented that there was significant correlation between SN-habenula functional connectivity and medication overuse over time (<italic>p</italic> = 0.043, <italic>r</italic> = 0.512, 95 %CI = 0.116–0.790). There were no significant correlations between SN-habenula connectivity and other clinical variables (<italic>p</italic> &gt; 0.05).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Correlation analysis between functional connectivity of habenula-SN and clinical variables of MOH + CM<sup>a</sup> subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Clinical variables</th><th align="left">r</th><th align="left"><italic>p</italic> value</th><th align="left">95 % CI of r</th></tr></thead><tbody><tr><td align="left">Headache history</td><td>0.103</td><td>0.703</td><td>-0.204–0.557</td></tr><tr><td align="left">Medication overuse duration</td><td>0.512</td><td>0.043</td><td>0.116–0.790</td></tr><tr><td align="left">Attack frequency</td><td>0.299</td><td>0.260</td><td>-0.451–0.702</td></tr><tr><td align="left">VAS<sup>b</sup></td><td>0.205</td><td>0.446</td><td>-0.300–0.714</td></tr><tr><td align="left">PHQ-9<sup>c</sup></td><td>0.482</td><td>0.158</td><td>-0.333–0.882</td></tr><tr><td align="left">GAD-7<sup>d</sup></td><td>0.206</td><td>0.568</td><td>-0.488–0.659</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> MOH + CM medication-overuse headache + chronic migraine; <sup>b</sup> VAS visual analog scale; <sup>c</sup> PHQ-9 Patient Health Questionnaire 9 Depression Scale; <sup>d</sup> GAD-7 Generalized Anxiety Disorder Assessment 7-item Scale</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation analysis between functional connectivity of habenula and SN and medication overuse duration. Correlation analysis results of the functional connectivity between habenula and SN and medication overuse duration. The relationship between these resting-state abnormalities and the other clinical variables were also checked. No results exceeded the threshold. SN, salience network</p></caption><graphic xlink:href="10194_2021_1318_Fig4_HTML" id="d32e1398"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec14" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par45">To the best of our knowledge, it is the first time that functional connectivity between the habenula and the SN in patients with MOH + CM and EM were investigated. Based on the independent component analysis (ICA) method, bilateral habenula showed increased resting-state functional connectivity with the SN in MOH + CM patients compared with EM and HC. Our results suggested this aberrant enhanced functional connectivity may play an important role in MOH and provided understanding for the pathophysiology of this condition.</p>
      <p id="Par46">So far, the pathophysiology of MOH has been believed to be associated with the central sensitization, deficit endogenous pain modulation, genetic predisposition, and substance addiction [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. As for MOH, the chronic pain itself is a complicated and multidimensional sensory experience that includes three domains: sensory, cognitive, and affective, which overlap largely with the function of the habenula and the SN [<xref ref-type="bibr" rid="CR35">35</xref>].</p>
      <p id="Par47">In the current study, the increased functional connectivity of habenula-SN was shown in patients with MOH and CM but not in EM or HC, or between subgroup of MOH + CM patients with or without depression, which indicated that this alteration may correlate with either repetitive headache attacks or overuse of medication. Previous studies have demonstrated increased functional connectivity and decreased gray matter volume within SN in MOH patients compared with healthy individuals [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], indicating the involvement of SN in MOH. In MOH patients who evolved from migraine, the dACC was demonstrated to be overactivated during switch between noxious and innocuous stimuli, yielding dysregulated salience processing of sensory in chronic migraine, and this overactivation to unspecific salient stimuli may play a role in migraine chronification [<xref ref-type="bibr" rid="CR37">37</xref>]. On the other hand, habenula activation has been observed in noxious stimulation together with increased functional connectivity with periaqueductal grey [<xref ref-type="bibr" rid="CR38">38</xref>]. The increased synchronous neuronal activity of habenula-SN is likely to correlate with the MOH processing and might contribute to the MOH development or chronification through aberrant overactivation to unspecific sensory stimuli.</p>
      <p id="Par48">MOH is hypothesized to be lying within a spectrum of addiction disorder involving the mesocorticolimbic dopamine system [<xref ref-type="bibr" rid="CR39">39</xref>]. As a core component of the brain anti-reward system, the lateral habenula receives input from limbic-forebrain and basal ganglia and sends output to midbrain nucleus including ventral tegmental area (VTA) and substantia nigra compacta (SNc) [<xref ref-type="bibr" rid="CR40">40</xref>]. The habenula is activated by exposure to negative reinforces such as pain or stress and provides inhibitory tone to decrease the activity of VTA and SNc. This will turn off the reward system and results in reduced dopamine release [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. As for MOH which evolves from a pre-existing headache, presumably the repetitive headache attacks may gradually reduce dopamine release through habenula during the process. The habenula-dopamine pathway was proved to motivate anticipation through the integrity of phasic salience-related signals and tonic reward-related signals [<xref ref-type="bibr" rid="CR43">43</xref>]. And the insula of SN was proved to charge in the conscious desire for drugs for it role in incentive motivation [<xref ref-type="bibr" rid="CR44">44</xref>]. Taken together, this habenula-SN dysfunction is likely to intervene with cognitive control to take the medications and fail to integrate motivational information in the long-term and may play a role in the development or the aggravation of MOH. Meanwhile, the increased functional connectivity of habenula-SN showed significant correlation with medication overuse duration, which indicated that the time length of medication overuse was related to the enhanced synchronous neuronal activity of habenula and SN. Furthermore, the habenula might be an efficient indicator or treatment target for MOH for its integrative role that covering multiple aspects of MOH.</p>
    </sec>
    <sec id="Sec15">
      <title>Limitations</title>
      <p id="Par49">Our study has several limitations. First, the sample size was limited. Second, the participants were not matched according to the depression or anxiety scale since the highly presence of depression in MOH population in the real world. Although PHQ-9 and GAD-7 scale were used as covariates to minimize these effects, and further subgroup comparisons within MOH patients were performed based on two scales, we cannot definitely exclude the possibility that part of the functional connectivity changes may be due to depression or anxiety. Third, we were not able to draw a causative relationship of the increased functional connectivity of habenula-SN and the MOH development. Fourth, we were not able to compare the habenula-SN functional connectivity amongst patients overusing different medications in MOH, since all our participants had overused combination analgesics. Previous studies based in China showed patients who overused combination analgesics and more than two kinds of analgesics accounted for almost 90 % of MOH [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. While triptan, ergotamine and opioid were rarely used either for its relatively high cost as a prescription only available in a few hospitals, or for its side effect and no longer available in the market, or strictly constricted [<xref ref-type="bibr" rid="CR2">2</xref>]. Meanwhile combination analgesics were available as over the counter at a relatively low price. Further studies are needed to clarify the effects of headache medications per se on the entity-specific alterations in the brain.</p>
    </sec>
    <sec id="Sec16" sec-type="conclusion">
      <title>Conclusions</title>
      <p id="Par50">The current study demonstrated an increased functional connectivity of habenula-SN in patients with MOH + CM compared with EM and HC by ICA-based analyses of RS-fMRI data. Our findings supported MOH to be lying within a spectrum of dependence and addiction disorder. The enhanced functional connectivity of the habenula with SN may correlate to the development or chronification of MOH. Furthermore, the habenula may be an indicator or treatment target for MOH for its integrative role involved in multiple aspects of MOH.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>MOH</term>
          <def>
            <p id="Par5">Medication-overuse headache</p>
          </def>
        </def-item>
        <def-item>
          <term>CM</term>
          <def>
            <p id="Par6">Chronic migraine</p>
          </def>
        </def-item>
        <def-item>
          <term>RS-fMRI</term>
          <def>
            <p id="Par7">Resting-state functional magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>SN</term>
          <def>
            <p id="Par8">Salience network</p>
          </def>
        </def-item>
        <def-item>
          <term>EM</term>
          <def>
            <p id="Par9">Episodic migraine</p>
          </def>
        </def-item>
        <def-item>
          <term>HC</term>
          <def>
            <p id="Par10">Healthy controls</p>
          </def>
        </def-item>
        <def-item>
          <term>PHQ-9</term>
          <def>
            <p id="Par11">Patient Health Questionnaire 9 Depression Scale</p>
          </def>
        </def-item>
        <def-item>
          <term>GAD-7</term>
          <def>
            <p id="Par12">Generalized Anxiety Disorder Assessment 7-item Scale</p>
          </def>
        </def-item>
        <def-item>
          <term>EPI</term>
          <def>
            <p id="Par13">Echo-planar imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>FSL</term>
          <def>
            <p id="Par14">FMRIB’s Software Library</p>
          </def>
        </def-item>
        <def-item>
          <term> BET</term>
          <def>
            <p id="Par15">Brain Extraction Tool</p>
          </def>
        </def-item>
        <def-item>
          <term>FWHM</term>
          <def>
            <p id="Par16"> Full width at half maximum</p>
          </def>
        </def-item>
        <def-item>
          <term>TC-GICA</term>
          <def>
            <p id="Par17">Temporal-concatenation group independent component analysis</p>
          </def>
        </def-item>
        <def-item>
          <term>MELODIC</term>
          <def>
            <p id="Par18">Multivariate Exploratory Linear Optimized Decomposition into Independent Components</p>
          </def>
        </def-item>
        <def-item>
          <term>ICA</term>
          <def>
            <p id="Par19"> Independent component analysis</p>
          </def>
        </def-item>
        <def-item>
          <term>FDR</term>
          <def>
            <p id="Par20"> False discovery rate</p>
          </def>
        </def-item>
        <def-item>
          <term>VTA</term>
          <def>
            <p id="Par21">Ventral tegmental area</p>
          </def>
        </def-item>
        <def-item>
          <term> SNc</term>
          <def>
            <p id="Par22">Substantia nigra compacta</p>
          </def>
        </def-item>
        <def-item>
          <term>dACC</term>
          <def>
            <p id="Par23">Dorsal anterior cingulate cortex</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Publisher’s Note</bold>
        </p>
        <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>Wei Dai and Enchao Qiu contributed equally to this work.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank all the participants and study sites that took part in this study.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Authors’ contributions</title>
      <p>WD, ZD, EQ and SY contributed the conception and design of the study. EQ, ZD, YC, XX, WX, MZ and KL contributed to MR data acquisition, and EQ, ZD, YC contributed the clinical data acquisition. WD, EQ and LT contributed the image analysis and statistical analysis, WD, ZD and EQ contributed to the interpretation and draft. WD, ZD, EQ, LT and SY contributed to the revision for important intellectual content. All authors read and approved the final manuscript.</p>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>This study was supported by the National Natural Science Foundation of China (grants 82071226, 81671077, 81771200), Beijing Nova Program (Z171100001117108, Z201100006820023), Beijing Natural Science Foundation Essential Research Project (Z170002).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Availability of data and materials</title>
      <p>All data generated and analyzed during the current study will be available from the corresponding author on reasonable request.</p>
    </notes>
    <notes>
      <title>Declarations</title>
      <notes id="FPar1">
        <title>Ethics approval and consent to participate</title>
        <p id="Par51">The Institutional Review Board of the Chinese PLA General Hospital approved the research protocol, and the procedures conformed to the tenets of the Declaration of Helsinki.</p>
      </notes>
      <notes id="FPar2">
        <title>Consent for publication</title>
        <p id="Par52">Not applicable.</p>
      </notes>
      <notes id="FPar3" notes-type="COI-statement">
        <title>Competing interests</title>
        <p id="Par53">The authors declare that they have no competing interests.</p>
      </notes>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>TJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medication-overuse headache in China: clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria</article-title>
          <source>Cephalalgia</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>644</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="doi">10.1177/0333102414552533</pub-id>
          <pub-id pub-id-type="pmid">25286910</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>López Martínez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pareja Román</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jiménez Hernández</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chronic Migraine with Medication Overuse: Clinical Pattern and Evolution from a Retrospective Cohort in Seville, Spain</article-title>
          <source>SN Compr Clin Med</source>
          <year>2020</year>
          <volume>2</volume>
          <fpage>1514</fpage>
          <lpage>1525</lpage>
          <pub-id pub-id-type="doi">10.1007/s42399-020-00424-8</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Creac’h</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guegan-Massardier</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria</article-title>
          <source>Headache</source>
          <year>2008</year>
          <volume>48</volume>
          <fpage>1026</fpage>
          <lpage>1036</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1526-4610.2007.00999.x</pub-id>
          <pub-id pub-id-type="pmid">18081820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The prevalence and burden of primary headaches in China: a population-based door-to-door survey</article-title>
          <source>Headache</source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>582</fpage>
          <lpage>591</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1526-4610.2011.02061.x</pub-id>
          <pub-id pub-id-type="pmid">22590713</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rates and Predictors of Relapse in Medication Overuse Headache: A Clinic-Based Study from China</article-title>
          <source>Eur Neurol</source>
          <year>2019</year>
          <volume>82</volume>
          <fpage>68</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1159/000504620</pub-id>
          <pub-id pub-id-type="pmid">31825923</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cevoli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mochi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scapoli</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse</article-title>
          <source>Eur J Neurol</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>1009</fpage>
          <lpage>1013</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2006.01415.x</pub-id>
          <pub-id pub-id-type="pmid">16930369</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Lorenzo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sances</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Di Lorenzo</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The wolframin His611Arg polymorphism influences medication overuse headache</article-title>
          <source>Neurosci Lett</source>
          <year>2007</year>
          <volume>424</volume>
          <fpage>179</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neulet.2007.07.037</pub-id>
          <pub-id pub-id-type="pmid">17719176</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chanraud</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Di Scala</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dilharreguy</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes?</article-title>
          <source>Cephalalgia</source>
          <year>2014</year>
          <volume>34</volume>
          <fpage>605</fpage>
          <lpage>615</lpage>
          <pub-id pub-id-type="doi">10.1177/0333102413519514</pub-id>
          <pub-id pub-id-type="pmid">24449748</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riederer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Marti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luechinger</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety</article-title>
          <source>World J Biol Psychia</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>517</fpage>
          <lpage>525</lpage>
          <pub-id pub-id-type="doi">10.3109/15622975.2012.665175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cupini</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sarchielli</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Degradation of endocannabinoids in chronic migraine and medication overuse headache</article-title>
          <source>Neurobiol Dis</source>
          <year>2008</year>
          <volume>30</volume>
          <fpage>186</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2008.01.003</pub-id>
          <pub-id pub-id-type="pmid">18358734</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Ornello</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Quatrosi</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medication overuse and drug addiction: a narrative review from addiction perspective</article-title>
          <source>J Headache Pain</source>
          <year>2021</year>
          <volume>22</volume>
          <fpage>32</fpage>
          <pub-id pub-id-type="doi">10.1186/s10194-021-01224-8</pub-id>
          <pub-id pub-id-type="pmid">33910499</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lanteri-Minet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>What is the role of dependence-related behavior in medication-overuse headache?</article-title>
          <source>Headache</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>1597</fpage>
          <lpage>1611</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1526-4610.2010.01755.x</pub-id>
          <pub-id pub-id-type="pmid">20807250</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuh</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>SR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Does medication overuse headache represent a behavior of dependence?</article-title>
          <source>Pain</source>
          <year>2005</year>
          <volume>119</volume>
          <fpage>49</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pain.2005.09.034</pub-id>
          <pub-id pub-id-type="pmid">16298069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferraro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grazzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Muffatti</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas</article-title>
          <source>Headache</source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>1520</fpage>
          <lpage>1534</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1526-4610.2012.02276.x</pub-id>
          <pub-id pub-id-type="pmid">23094707</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vandenbussche</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Laterza</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lisicki</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medication-overuse headache: a widely recognized entity amidst ongoing debate</article-title>
          <source>J Headache Pain</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>50</fpage>
          <pub-id pub-id-type="doi">10.1186/s10194-018-0875-x</pub-id>
          <pub-id pub-id-type="pmid">30003412</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torta</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Luda</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleus accumbens functional connectivity discriminates medication-overuse headache</article-title>
          <source>Neuroimage Clin</source>
          <year>2016</year>
          <volume>11</volume>
          <fpage>686</fpage>
          <lpage>693</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nicl.2016.05.007</pub-id>
          <pub-id pub-id-type="pmid">27330969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berridge</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?</article-title>
          <source>Brain Res Brain Res Rev</source>
          <year>1998</year>
          <volume>28</volume>
          <fpage>309</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1016/s0165-0173(98)00019-8</pub-id>
          <pub-id pub-id-type="pmid">9858756</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Androulakis</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Rorden</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Peterlin</surname>
              <given-names>BL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of salience network intranetwork resting state functional connectivity in women with chronic migraine</article-title>
          <source>Cephalalgia</source>
          <year>2018</year>
          <volume>38</volume>
          <fpage>1731</fpage>
          <lpage>1741</lpage>
          <pub-id pub-id-type="doi">10.1177/0333102417748570</pub-id>
          <pub-id pub-id-type="pmid">29237282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Proulx</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Hikosaka</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Malinow</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Reward processing by the lateral habenula in normal and depressive behaviors</article-title>
          <source>Nature neuroscience</source>
          <year>2014</year>
          <volume>17</volume>
          <fpage>1146</fpage>
          <lpage>1152</lpage>
          <pub-id pub-id-type="doi">10.1038/nn.3779</pub-id>
          <pub-id pub-id-type="pmid">25157511</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hikosaka</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The habenula: from stress evasion to value-based decision-making</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>503</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn2866</pub-id>
          <pub-id pub-id-type="pmid">20559337</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borsook</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Elman</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pain and analgesia: the value of salience circuits</article-title>
          <source>Prog Neurobiol</source>
          <year>2013</year>
          <volume>104</volume>
          <fpage>93</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pneurobio.2013.02.003</pub-id>
          <pub-id pub-id-type="pmid">23499729</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="other">Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification ofHeadache Disorders, 3rd edition Cephalalgia 38: 1-211. 10.1177/0333102417738202</mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">Smith SM, Jenkinson M, Woolrich MW et al (2004) Advances in functional and structural MR image analysis andimplementation as FSL. Neuroimage 23 Suppl 1: S208-219. 10.1016/j.neuroimage.2004.07.051</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qiu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Abnormal coactivation of the hypothalamus and salience network in patients with cluster headache</article-title>
          <source>Neurology</source>
          <year>2015</year>
          <volume>84</volume>
          <fpage>1402</fpage>
          <lpage>1408</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0000000000001442</pub-id>
          <pub-id pub-id-type="pmid">25746559</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Association between resting-state coactivation in the parieto-frontal network and intelligence during late childhood and adolescence</article-title>
          <source>Am J Neuroradiol</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>1150</fpage>
          <lpage>1156</lpage>
          <pub-id pub-id-type="doi">10.3174/ajnr.A3850</pub-id>
          <pub-id pub-id-type="pmid">24557703</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial vs. Temporal Features in ICA of Resting-State fMRI - A Quantitative and Qualitative Investigation in the Context of Response Inhibition</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>e66572</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0066572</pub-id>
          <pub-id pub-id-type="pmid">23825545</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beckmann</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Probabilistic independent component analysis for functional magnetic resonance imaging</article-title>
          <source>IEEE Trans Med Imaging</source>
          <year>2004</year>
          <volume>23</volume>
          <fpage>137</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="doi">10.1109/TMI.2003.822821</pub-id>
          <pub-id pub-id-type="pmid">14964560</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filippini</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>MacIntosh</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Hough</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>7209</fpage>
          <lpage>7214</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0811879106</pub-id>
          <pub-id pub-id-type="pmid">19357304</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeo</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Krienen</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Sepulcre</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The organization of the human cerebral cortex estimated by intrinsic functional connectivity</article-title>
          <source>J Neurophysiol</source>
          <year>2011</year>
          <volume>106</volume>
          <fpage>1125</fpage>
          <lpage>1165</lpage>
          <pub-id pub-id-type="doi">10.1152/jn.00338.2011</pub-id>
          <pub-id pub-id-type="pmid">21653723</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="data">
          <name>
            <surname>Yan</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>XD</given-names>
          </name>
          <name>
            <surname>Zuo</surname>
            <given-names>XN</given-names>
          </name>
          <etal/>
          <year>2016</year>
          <data-title>DPABI: Data Processing &amp; Analysis for (Resting-State)</data-title>
          <pub-id pub-id-type="doi">10.1007/s12021-016-9299-4</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ely</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>WK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resting-state functional connectivity of the human habenula in healthy individuals: Associations with subclinical depression</article-title>
          <source>Hum Brain Mapp</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>2369</fpage>
          <lpage>2384</lpage>
          <pub-id pub-id-type="doi">10.1002/hbm.23179</pub-id>
          <pub-id pub-id-type="pmid">26991474</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seeley</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Schatzberg</surname>
              <given-names>AF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dissociable intrinsic connectivity networks for salience processing and executive control</article-title>
          <source>J Neurosci</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>2349</fpage>
          <lpage>2356</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5587-06.2007</pub-id>
          <pub-id pub-id-type="pmid">17329432</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diener</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Holle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Solbach</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Medication-overuse headache: risk factors, pathophysiology and management</article-title>
          <source>Nat Rev Neurol</source>
          <year>2016</year>
          <volume>12</volume>
          <fpage>575</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="doi">10.1038/nrneurol.2016.124</pub-id>
          <pub-id pub-id-type="pmid">27615418</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lai</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Neuroimaging Findings in Patients with Medication Overuse Headache</article-title>
          <source>Curr Pain Headache Rep</source>
          <year>2018</year>
          <volume>22</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="doi">10.1007/s11916-018-0661-0</pub-id>
          <pub-id pub-id-type="pmid">29340793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paolucci</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saraceni</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Piccinini</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Management of chronic pain in osteoporosis: challenges and solutions</article-title>
          <source>J Pain Res</source>
          <year>2016</year>
          <volume>9</volume>
          <fpage>177</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="doi">10.2147/JPR.S83574</pub-id>
          <pub-id pub-id-type="pmid">27099529</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michels</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Christidi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Steiger</surname>
              <given-names>VR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain - A multimodal MRI study</article-title>
          <source>Cephalalgia</source>
          <year>2017</year>
          <volume>37</volume>
          <fpage>764</fpage>
          <lpage>779</lpage>
          <pub-id pub-id-type="doi">10.1177/0333102416652625</pub-id>
          <pub-id pub-id-type="pmid">27250235</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogdanov</surname>
              <given-names>VB</given-names>
            </name>
            <name>
              <surname>Bogdanova</surname>
              <given-names>OV</given-names>
            </name>
            <name>
              <surname>Vigano</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased cerebral responses to salient transitions between alternating stimuli in chronic migraine with medication overuse headache and during migraine attacks</article-title>
          <source>Cephalalgia</source>
          <year>2019</year>
          <volume>39</volume>
          <fpage>988</fpage>
          <lpage>999</lpage>
          <pub-id pub-id-type="doi">10.1177/0333102418825359</pub-id>
          <pub-id pub-id-type="pmid">30786732</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shelton</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pendse</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Maleki</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mapping pain activation and connectivity of the human habenula</article-title>
          <source>J Neurophysiol</source>
          <year>2012</year>
          <volume>107</volume>
          <fpage>2633</fpage>
          <lpage>2648</lpage>
          <pub-id pub-id-type="doi">10.1152/jn.00012.2012</pub-id>
          <pub-id pub-id-type="pmid">22323632</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferraro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grazzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mandelli</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study</article-title>
          <source>Pain Med</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>255</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1526-4637.2011.01183.x</pub-id>
          <pub-id pub-id-type="pmid">21749635</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hikosaka</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Lateral habenula as a source of negative reward signals in dopamine neurons</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>447</volume>
          <fpage>1111</fpage>
          <lpage>1115</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05860</pub-id>
          <pub-id pub-id-type="pmid">17522629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinschwitz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dittgen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Madai</surname>
              <given-names>VI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glutamatergic axons from the lateral habenula mainly terminate on GABAergic neurons of the ventral midbrain</article-title>
          <source>Neuroscience</source>
          <year>2010</year>
          <volume>168</volume>
          <fpage>463</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.03.050</pub-id>
          <pub-id pub-id-type="pmid">20353812</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christoph</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Leonzio</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Wilcox</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat</article-title>
          <source>J Neurosci</source>
          <year>1986</year>
          <volume>6</volume>
          <fpage>613</fpage>
          <lpage>619</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.06-03-00613.1986</pub-id>
          <pub-id pub-id-type="pmid">3958786</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bromberg-Martin</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hikosaka</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Distinct tonic and phasic anticipatory activity in lateral habenula and dopamine neurons</article-title>
          <source>Neuron</source>
          <year>2010</year>
          <volume>67</volume>
          <fpage>144</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2010.06.016</pub-id>
          <pub-id pub-id-type="pmid">20624598</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naqvi</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Gaznick</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tranel</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The insula: a critical neural substrate for craving and drug seeking under conflict and risk</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2014</year>
          <volume>1316</volume>
          <fpage>53</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1111/nyas.12415</pub-id>
          <pub-id pub-id-type="pmid">24690001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Classification and clinical features of headache patients: an outpatient clinic study from China</article-title>
          <source>J Headache Pain</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>561</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="doi">10.1007/s10194-011-0360-2</pub-id>
          <pub-id pub-id-type="pmid">21744226</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
